Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2004-11-1
pubmed:abstractText
Wilson's disease is an inherited copper toxicosis caused by defective putative copper transporting ATPase in the liver. Because of impaired biliary secretion, copper remains in the liver, resulting in chronic hepatic lesions including fatty metamorphosis, chronic hepatitis and cirrhosis. In the latter stage, extrapyramidal syndromes may develop with and without symptomatic hepatic lesions. Acute liver damage associated with hemolysis and deep jaundice may be the first manifestation. The majority of patients show hypoceruloplasminemia, which has been used as a screening test for the disease. A large number of mutations in the ATP7B gene have been reported. Thus, genetic diagnosis might be limitedly used to presymptomatic diagnosis of siblings when mutations are identified in an index patient. Introduction of penicillamine caused a revolution in the treatment of patients. Another chelater, trientine, is now available for those intolerant of penicillamine. Tetrathiomolibdate and zinc acetate are additional alternatives currently being tested. Hypoceruloplasminemia and further reduction after chelation therapy may be associated with iron overload. This complication is closely related with impaired transport of ferrous ion due to ferroxidase deficiency. Noncompliance and teratogenicity are other major concerns because any treatment with the agents listed above is a life long regimen. Despite various side effects of penicillamine, its teratogenicity is negligible. These data indicate that penicillamine is the first choice of drug for this disease.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphatases, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Cation Transport Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ceruloplasmin, http://linkedlifedata.com/resource/pubmed/chemical/Chelating Agents, http://linkedlifedata.com/resource/pubmed/chemical/Copper, http://linkedlifedata.com/resource/pubmed/chemical/Iron, http://linkedlifedata.com/resource/pubmed/chemical/Molybdenum, http://linkedlifedata.com/resource/pubmed/chemical/Penicillamine, http://linkedlifedata.com/resource/pubmed/chemical/Wilson disease protein, http://linkedlifedata.com/resource/pubmed/chemical/Zinc Acetate, http://linkedlifedata.com/resource/pubmed/chemical/tetrathiomolybdate
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0031-6903
pubmed:author
pubmed:issnType
Print
pubmed:volume
124
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
711-24
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15516801-Adenosine Triphosphatases, pubmed-meshheading:15516801-Biological Markers, pubmed-meshheading:15516801-Cation Transport Proteins, pubmed-meshheading:15516801-Ceruloplasmin, pubmed-meshheading:15516801-Chelating Agents, pubmed-meshheading:15516801-Chelation Therapy, pubmed-meshheading:15516801-Copper, pubmed-meshheading:15516801-Female, pubmed-meshheading:15516801-Hepatolenticular Degeneration, pubmed-meshheading:15516801-Humans, pubmed-meshheading:15516801-Iron, pubmed-meshheading:15516801-Male, pubmed-meshheading:15516801-Molecular Diagnostic Techniques, pubmed-meshheading:15516801-Molybdenum, pubmed-meshheading:15516801-Mutation, pubmed-meshheading:15516801-Penicillamine, pubmed-meshheading:15516801-Pregnancy, pubmed-meshheading:15516801-Pregnancy Outcome, pubmed-meshheading:15516801-Zinc Acetate
pubmed:year
2004
pubmed:articleTitle
[Wilson's disease and its pharmacological treatment].
pubmed:affiliation
Department of Medicine, Faculty of Pharmaceutical Sciences of Hokuriku University, Kanazawa 920-1181, Japan. h-hayashi@hokuriku-u.ac.jp
pubmed:publicationType
Journal Article, English Abstract, Review